Key Takeaways:
- Colgate-Palmolive Q1 2026 adjusted EPS of $0.97 beat the IBES estimate of $0.95, driven by strong international demand and broad-based organic sales growth, lifting net sales 8.4% to $5.3 billion.
- CL stock could rise from $91 to around $107 per share by December 2028, based on our valuation assumptions.
- That implies a total return of around 18% and an annualized return of around 6% over the next 2.6 years.
What Happened?
Colgate-Palmolive Company (CL) reported a solid Q1 FY2026 result that topped analyst expectations. Adjusted EPS of $0.97 beat the $0.95 consensus estimate. Net sales rose 8.4% to $5.3 billion, with growth broad-based across geographies. Investors initially cheered the beat, but sentiment has since turned more cautious.
The company warned of a $300 million cost hit from the Middle East conflict. This headwind relates to disruptions in raw material supply chains that run through the region. Input costs, particularly resins, are also a concern highlighted by TD Cowen in a March 2026 analyst note downgrading the stock. These pressures are weighing on margin expectations even as top-line growth remains healthy.
Full-year FY2025 net sales climbed to $20.4 billion per the company’s annual report. Colgate Palmolive India posted a higher quarterly adjusted profit in May 2026, driven by premium product demand in developing markets. Deutsche Bank upgraded the stock in March 2026, and the company named Betsy Fishbone as chief legal officer in April 2026. These moves reflect ongoing governance and strategic execution.
The Street consensus target stands at around $96, roughly in line with the current price. Shareholders voted at the May 2026 annual meeting to reaffirm leadership’s direction. The company is scheduled to present at the dbAccess Global Consumer Conference in June 2026.
Here’s why Colgate-Palmolive stock could offer solid capital returns through 2028 as its core business drivers support shareholder value.
What the Model Says for CL Stock
We analyzed the upside potential for Colgate-Palmolive stock based on its durable global consumer brand portfolio, steady organic volume recovery, and ongoing cost discipline across oral care, personal care, and home care categories.
Based on estimates of 3.9% annual revenue growth, 21.3% operating margins, and a normalized P/E multiple of 22.4x, the model projects Colgate-Palmolive stock could rise from $91 to around $107 per share.
That would be a 17.5% total return, or a 6.4% annualized return over the next 2.6 years.
Our Valuation Assumptions
TIKR’s Valuation Model lets you plug in your own assumptions for a company’s revenue growth, operating margins, and P/E multiple, and calculates the stock’s expected returns.
Here’s what we used for CL stock:
1. Revenue Growth: 3.9%
Colgate-Palmolive generates revenue across more than 200 countries and territories, giving it unmatched geographic diversification among consumer staples peers. The one-year revenue CAGR of 1.4% was modest, but the five-year CAGR of 4.4% reflects the steady compounding nature of consumer staples demand. Forward estimates are more constructive, driven by premium product expansion in emerging markets.
Colgate Palmolive India’s strong Q1 FY2026 result illustrates how premiumization in developing markets can outpace mature market trends. Management has also invested in innovation to drive category growth in oral care and personal care.
Based on analysts’ consensus estimates, we used a 3.9% revenue growth rate. This reflects a normalization of volume growth and accounts for modest pricing contribution and geographic mix improvement as international markets continue to outperform.
2. Operating Margins: 21.3%
Colgate-Palmolive’s LTM EBIT margin of 20.6% is strong for a consumer staples company. Gross margins of 60.1% reflect the pricing power embedded in the Colgate and Palmolive brand portfolios. However, the $300 million Middle East cost headwind announced in Q1 2026 introduces near-term margin uncertainty.
Resin and commodity cost pressures flagged by analysts add another variable to the margin outlook. LTM ROIC of 49.5% reflects the exceptional capital efficiency of the business model despite current headwinds.
Based on analysts’ consensus estimates, we used 21.3% operating margins. This reflects a slight recovery from current levels as commodity headwinds ease and pricing actions flow through, consistent with the company’s track record of margin management over time.
3. Exit P/E Multiple: 22.4x
Colgate-Palmolive trades at an NTM P/E of around 24x and an LTM P/E of around 35x. Consumer staples companies with strong global brands typically trade at premium multiples because of their defensive earnings profile and reliable dividend history. The forward multiple is more modest than the LTM level, reflecting earnings normalization expectations.
A 22.4x exit P/E sits at the lower end of Colgate’s historical trading range. This acknowledges that the stock may not re-rate significantly without a meaningful acceleration in organic volume growth.
Based on analysts’ consensus estimates, we used a 22.4x exit multiple. This accounts for the 2.4% dividend yield, the strong global brand portfolio, and the headwinds from commodity costs and geopolitical supply chain disruptions currently pressuring margins.
Build your own Valuation Model to value any stock (It’s free!) >>>
What Happens If Things Go Better or Worse?
Different scenarios for CL stock through 2030 show varied outcomes based on organic volume recovery speed and commodity cost trends (these are estimates, not guaranteed returns):
- Low Case: Commodity cost pressures persist and volume recovery stalls below expectations → 4.2% annual returns
- Mid Case: Organic growth normalizes, and margins recover modestly as headwinds ease → 6.8% annual returns
- High Case: Premiumization accelerates in emerging markets, and input costs ease faster than expected → 9.0% annual returns
Going forward, Colgate-Palmolive’s return profile is shaped by the pace of input cost normalization and the company’s ability to sustain pricing in competitive consumer markets. The 6.4% near-term annualized return is modest, but it reflects the stock’s defensive characteristics and income profile. Income-oriented investors may find the dividend yield and stability meaningful at current levels.
See what analysts think about CL stock right now (Free with TIKR) >>>
Should You Invest in Colgate-Palmolive?
The only way to really know is to look at the numbers yourself. TIKR gives you free access to the same institutional-quality financial data that professional analysts use to answer exactly that question.
Pull up CL, and you’ll see years of historical financials, what Wall Street analysts expect for revenue and earnings in the quarters ahead, how valuation multiples have moved over time, and whether price targets are trending up or down.
You can build a free watchlist to track CL alongside every other stock on your radar. No credit card required. Just the data you need to decide for yourself.
Analyze the stock on TIKR Free→
Looking for New Opportunities?
- See what stock billionaire investors are buying so you can follow the smart money.
- Analyze stocks in as little as 5 minutes with TIKR’s all-in-one, easy-to-use platform.
- The more rocks you overturn… the more opportunities you’ll uncover. Search 100K+ global stocks, global top investor holdings, and more with TIKR.
Disclaimer:
Please note that the articles on TIKR are not intended to serve as investment or financial advice from TIKR or our content team, nor are they recommendations to buy or sell any stocks. We create our content based on TIKR Terminal’s investment data and analysts’ estimates. Our analysis might not include recent company news or important updates. TIKR has no position in any stocks mentioned. Thank you for reading, and happy investing!
